Shandong Wohua Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002107.SZ

Shandong Wohua Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 343.17 M

Shandong Wohua Pharmaceutical Co., Ltd. Market Capitalization is USD 343.17 M on January 14, 2025, a -29.86% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Shandong Wohua Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 489.25 M on January 15, 2024, which is 42.57% above the current Market Capitalization.
Shandong Wohua Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 284.74 M on February 07, 2024, which is -17.03% below the current Market Capitalization.
Shandong Wohua Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 362.11 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002107.SZ

Shandong Wohua Pharmaceutical Co., Ltd.

CEO	Ms. Yingzi Zeng
IPO Date	Jan. 24, 2007
Location	China
Headquarters	No. 3517 Liyuan Street
Employees	1,353
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Key trends

Past 5 years